Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.19.3.a.u2
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenues:      
Total revenues $ 68,458 $ 60,594 $ 50,024
Costs and operating expenses:      
Cost of product revenue 15,632 12,620 14,327
Research and development 33,873 29,978 29,659
Selling, general and administrative 31,502 29,291 29,008
Total costs and operating expenses 81,007 71,889 72,994
Income (loss) from operations (12,549) (11,295) (22,970)
Interest income 1,287 671 147
Other expenses, net (656) (291) (92)
Loss before income taxes (11,918) (10,915) (22,915)
Provision for (benefit from) income taxes 17 (37) 81
Net loss $ (11,935) $ (10,878) $ (22,996)
Net loss per share, basic and diluted (usd per share) $ (0.21) $ (0.21) $ (0.50)
Weighted average common stock shares used in computing net loss per share, basic and diluted (shares) 56,525 52,205 46,228
Product Sales      
Revenues:      
Total revenues $ 29,465 $ 25,590 $ 26,685
Research and Development Revenues      
Revenues:      
Total revenues $ 38,993 $ 35,004 $ 23,339